PARSIPPANY, N.J., Feb. 7 /PRNewswire/ -- EBI, the leader in Bone Growth
Technologies, introduces a NEW line of Osteobiologics: Pro Osteon(R)
Osteobiologics. In addition to Traditional Allograft, Resorbable Granules and
Blocks, Synthetic Bone Graft Substitutes and DBM Putty, the NEW Pro Osteon
line now includes: DBM Paste, Bone Marrow Aspirate and Concentrators, Bone
Void Fillers and Machined Graft Substitutes.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050207/NYM210LOGO )
The family of osteobiologics may have some or all of the following
characteristics: mixable, moldable, bendable, injectable and resorbable; they
mimic cancellous and cortical tissue, are osteoconductive and mix easily with
osteoinductive and osteogenic materials -- to maximize a surgeon's surgical
options. When used adjunctively with the proven technologies of EBI(R) Bone
Growth Stimulation for spine and appendicular applications, this new line
addresses the needs of the surgeon, hospital and patient to create a full line
of choices for Bone Growth Technologies that are cost effective.
EBI, L.P., founded in 1979, develops, manufactures and markets a complete
line of Bone Growth Technologies, External and Internal Fixation, Spine and
Sports Medicine products.
For more information, please visit the EBI website at:
http://www.ebimedical.com or call (800) 526-2579 from 8:30 am to 5:00 pm EST.
Unless otherwise indicated, (TM) denotes a trademark, and (R) denotes a
registered trademark, of one of the following companies: Biomet, Inc.;
Electro-Biology, Inc.; EBI, L.P.; Biolectron, Inc.; EBI Medical Systems, Inc.;
Interpore Cross International, Inc., Cross Medical Products, Inc.; or
Interpore Orthopaedics, Inc.